Literature DB >> 10550815

Further crossvalidation of regression-based neuropsychological norms with an update for the Boston Naming Test.

R K Heaton1, N Avitable, I Grant, C G Matthews.   

Abstract

Regression-based norms for the Trail Making Test, Boston Naming Test, and Wisconsin Card Sorting Test, which we published in 1991 and 1993, have been criticized by Fastenau (1998) as having overcorrected for demographic influences in a sample of 63 older adults. We present data from new, independent participant samples that are consistent with expectations from the regression-based norms. We propose that Fastenau's findings in this instance resulted from the nonrepresentative nature of his relatively small sample, rather than from statistical deficiencies of regression based norms. Our currently published norms on one of the four tests considered here, the Boston Naming Test, are based upon a participant sample that was small and had inadequate representation of young adults. We address this by providing updated norms based on a much larger and more representative sample (N = 531).

Entities:  

Mesh:

Year:  1999        PMID: 10550815     DOI: 10.1076/jcen.21.4.572.882

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  17 in total

1.  Caveats in the neuropsychological assessment of African Americans.

Authors:  Alfonso L Campbell; Carlota Ocampo; Kashemi DeShawn Rorie; Sonya Lewis; Shawn Combs; Phyllis Ford-Booker; Juanita Briscoe; Ometha Lewis-Jack; Andrew Brown; Don Wood; Gary Dennis; Roger Weir; Alicia Hastings
Journal:  J Natl Med Assoc       Date:  2002-07       Impact factor: 1.798

2.  HIV proviral DNA associated with decreased neuropsychological function.

Authors:  Bruce Shiramizu; Robert Paul; Andrew Williams; Cecilia Shikuma; Michael Watters; John Grove; Victor Valcour
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2007       Impact factor: 2.198

3.  Effects of perceptual and contextual enrichment on visual confrontation naming in adult aging.

Authors:  Yvonne Rogalski; Jonathan E Peelle; Jamie Reilly
Journal:  J Speech Lang Hear Res       Date:  2011-04-15       Impact factor: 2.297

4.  Robust and conventional neuropsychological norms: diagnosis and prediction of age-related cognitive decline.

Authors:  Susan De Santi; Elizabeth Pirraglia; William Barr; James Babb; Schantel Williams; Kimberley Rogers; Lidia Glodzik; Miroslaw Brys; Lisa Mosconi; Barry Reisberg; Steven Ferris; Mony J de Leon
Journal:  Neuropsychology       Date:  2008-07       Impact factor: 3.295

5.  Predictors of HVOT performance in Parkinson's disease.

Authors:  Christopher I Higginson; Vicki L Wheelock; Dawn Levine; Conrad T E Pappas; Karen A Sigvardt
Journal:  Appl Neuropsychol       Date:  2011-07

6.  Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates.

Authors:  Mark W Bondi; Emily C Edmonds; Amy J Jak; Lindsay R Clark; Lisa Delano-Wood; Carrie R McDonald; Daniel A Nation; David J Libon; Rhoda Au; Douglas Galasko; David P Salmon
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

7.  Prophylactic Treatments for Anomia in the Logopenic Variant of Primary Progressive Aphasia: Cross-Language Transfer.

Authors:  Aaron M Meyer; Sarah F Snider; Carol B Eckmann; Rhonda B Friedman
Journal:  Aphasiology       Date:  2015       Impact factor: 2.773

8.  Amount of HIV DNA in peripheral blood mononuclear cells is proportional to the severity of HIV-1-associated neurocognitive disorders.

Authors:  Bruce Shiramizu; Andrew E Williams; Cecilia Shikuma; Victor Valcour
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2009       Impact factor: 2.198

9.  Route learning impairment in temporal lobe epilepsy.

Authors:  Brian D Bell
Journal:  Epilepsy Behav       Date:  2012-10-04       Impact factor: 2.937

10.  Neuropsychological performance in advanced age: influences of demographic factors and Apolipoprotein E: findings from the Cache County Memory Study.

Authors:  Katheen A Welsh-Bohmer; Truls Ostbye; Linda Sanders; Carl F Pieper; Kathleen M Hayden; JoAnn T Tschanz; Maria C Norton
Journal:  Clin Neuropsychol       Date:  2008-06-10       Impact factor: 3.535

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.